Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Anesthesia management during cataract surgery
| Anesthesia management during cataract surgery |
| Autore | Schein Oliver D |
| Pubbl/distr/stampa | [Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2001 |
| Descrizione fisica | 1 online resource |
| Collana |
Evidence Reports/Technology Assessments
AHRQ publication |
| Soggetto topico |
Investigative Techniques
Anesthesia Health Care Evaluation Mechanisms Refractive Surgical Procedures Quality of Health Care Ophthalmologic Surgical Procedures Diagnostic Techniques and Procedures Anesthesia and Analgesia Health Care Quality, Access, and Evaluation Surgical Procedures, Operative Health Care Anesthesia, Conduction Cataract Extraction Evaluation Studies as Topic Medicine Health & Biological Sciences Ophthalmology & Optometry |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910693524003321 |
Schein Oliver D
|
||
| [Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2001 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910139613803321 |
|
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910808713803321 |
|
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program [[electronic resource]]
| Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program [[electronic resource]] |
| Autore | Staff Institute of Medicine |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2002 |
| Descrizione fisica | 1 online resource (179 p.) |
| Disciplina | 615 |
| Soggetto topico |
Anthrax -- Vaccination
Public health Anthrax - Vaccination - Research - United States Bacterial Vaccines Evaluation Studies as Topic Health Care Evaluation Mechanisms Quality of Health Care Bacillaceae Infections Investigative Techniques Vaccines Health Services Administration Gram-Positive Bacterial Infections Bacterial Infections Health Care Quality, Access, and Evaluation Health Care Analytical, Diagnostic and Therapeutic Techniques and Equipment Biological Products Complex Mixtures Bacterial Infections and Mycoses Chemicals and Drugs Diseases Program Evaluation Drug Evaluation Anthrax Anthrax Vaccines Public Health Health & Biological Sciences Communicable Diseases |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-50374-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas""
""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1"" ""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1"" |
| Record Nr. | UNINA-9910455868803321 |
|
Staff Institute of Medicine
|
||
| Washington, : National Academies Press, 2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]]
| Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]] |
| Autore | Staff Institute of Medicine |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2002 |
| Descrizione fisica | 1 online resource (179 p.) |
| Disciplina | 615 |
| Soggetto topico |
Anthrax -- Vaccination
Public health Anthrax - Vaccination - Research - United States Bacterial Vaccines Evaluation Studies as Topic Health Care Evaluation Mechanisms Quality of Health Care Bacillaceae Infections Investigative Techniques Vaccines Health Services Administration Gram-Positive Bacterial Infections Bacterial Infections Health Care Quality, Access, and Evaluation Health Care Biological Products Complex Mixtures Bacterial Infections and Mycoses Diseases Program Evaluation Drug Evaluation Anthrax Anthrax Vaccines Public Health Health & Biological Sciences Communicable Diseases |
| ISBN | 0-309-50374-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas""
""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1"" ""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1"" |
| Record Nr. | UNINA-9910780301103321 |
|
Staff Institute of Medicine
|
||
| Washington, : National Academies Press, 2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Basic Methods for Assessment of Renal Fluoride Excretion in Community Prevention Programmes for Oral Health [[electronic resource]]
| Basic Methods for Assessment of Renal Fluoride Excretion in Community Prevention Programmes for Oral Health [[electronic resource]] |
| Autore | WHO |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (91 p.) |
| Disciplina |
617.6/01
617.601 |
| Collana | Nonserial Publications |
| Soggetto topico |
Dental hygiene
Dental pharmacology Pharmacology Water - Fluoridation - Health aspects Quality of Health Care Health Services Administration Evaluation Studies as Topic Health Care Evaluation Mechanisms Investigative Techniques Public Health Dentistry Water Supply Tooth Diseases Body Fluids Hydrofluoric Acid Preventive Dentistry Anions Dentistry Fluids and Secretions Health Care Fluorine Compounds Environment and Public Health Specialties, Dental Ions Sanitary Engineering Stomatognathic Diseases Sanitation Inorganic Chemicals Anatomy Health Care Quality, Access, and Evaluation Diseases Electrolytes Health Occupations Public Health Occupations Methods Program Evaluation Fluoridation Fluorosis, Dental Fluorides Organization and Administration Urine Community Dentistry Health & Biological Sciences Environmental Health |
| Soggetto genere / forma | Electronic books. |
| ISBN | 92-4-069211-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Acronyms and abbreviations; Preface; Acknowledgements; 1 Introduction; 1.1 Background; 1.2 Sources of fluoride intake in humans; 1.3 Fluoride metabolism and excretion; 1.4 Biomarkers of fluoride exposure; 1.5 Urinary fluoride assessments in population oral health; 1.6 Areas of uncertainty; 2 General design of study; 2.1 Background; 2.2 Identification of participants; 2.3 Sampling; Location; Number of subjects; Age groups; Frequency; Time of study and number of days; 2.4 Methods of monitoring; 2.4.1 24-hour urine collection
2.4.2 Timed collections of urine obtained from defined periods of a day3 Methods for collecting urine, and for handling and evaluating results; 3.1 Recording of information; 3.1.1 General information; Figures; Figure 3.1 Example of daytime label used in time-controlled collections, to be attached to the urine collecting jar (WHO Form No. 96392, modified); Figure 3.2 Overnight urine collection label used in time-controlled collections (WHO Form No. 96393); Figure 3.3 Summary record form of urine collection from a group of children in time-controlled collections (WHO Form No. 96391) 3.1.2 Personal informationFigure 3.4 Sample invitation; Figure 3.5 Questionnaire on use of fluoride supplements and toothpaste; 3.2 Essential preparatory practices; 3.2.1 Pre-collection planning approaches; 4 Twenty-four hour urine collection; 4.1 Procedure; 4.2 Fluoride and creatinine concentrations; 4.3 Information to be recorded; 4.4 Determination of fluoride in urine; 4.5 General rules for tabulation and processing of data; 5 Design of the final report for 24-hour urine collection; 5.1 Introduction; 5.2 Materials and methods; 5.3 Results; Tables Table 5.1 Urinary fluoride excretion data from 24-hour urine collections5.4 Discussion and conclusion; 5.5 Summary; 5.6 Tables for the 24-hour collection method; Table 5.2 Criteria for cleaning data from children aged 2-6 years, from 24-hour collections; Table 5.3 Standards for urinary fluoride excretion (mg/24-hour cycle): lower and upper margins; Table 5.4 Calculated daily urinary fluoride excretion associated with low, optimal and high fluoride intake for ages 1-14 years Table 5.5 Calculated daily urinary fluoride excretion associated with low, optimal and high fluoride intake for broader age groups6 Collections of 8-18 hours (within the 24-hour cycle); 6.1 Collection of nocturnal urine and during periods of high excretion; 6.2 Optional calculations obtained from time-controlled urine collection - Use of a standardized format; 6.2.1 Coded recordings of personal data and individual fluoride exposure; 6.2.2 Standard table for surveys with 24-hour collections; 6.2.3 Standard table for surveys with two collections totalling 14-16 hours, using MS Excel 6.2.4 Standard table for surveys with three collections totalling 14-16 hours using MS Excel: complete series |
| Record Nr. | UNINA-9910464530403321 |
|
WHO
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac resynchronization therapy for congestive heart failure : prepared for agency for healthcare research and quality
| Cardiac resynchronization therapy for congestive heart failure : prepared for agency for healthcare research and quality |
| Pubbl/distr/stampa | [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004 |
| Collana |
Evidence report/technology assessment. Summary
AHRQ pub. |
| Soggetto topico |
Controlled Clinical Trials as Topic
Clinical Medicine Electric Stimulation Therapy Evidence-Based Practice Heart Diseases Clinical Trials as Topic Cardiovascular Diseases Medicine Therapeutics Health Occupations Evaluation Studies as Topic Epidemiologic Studies Diseases Diagnostic Techniques and Procedures Health Care Evaluation Mechanisms Epidemiologic Methods Investigative Techniques Public Health Quality of Health Care Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Evidence-Based Medicine Randomized Controlled Trials as Topic Cardiac Pacing, Artificial Heart Failure |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910693974603321 |
| [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]]
| Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]] |
| Autore | Bohaychuk Wendy |
| Pubbl/distr/stampa | Chichester ; ; New York, : John Wiley, c1999 |
| Descrizione fisica | 1 online resource (xiv, 211 p. ) |
| Disciplina | 615/.1901 |
| Altri autori (Persone) | BallGraham |
| Soggetto topico |
Clinical trials - Standards
Drugs - Testing - Standards Onderzoek Geneeskunde Clinical Trials as Topic - standards Drug Evaluation - standards Drug Evaluation, Preclinical Evaluation Studies as Topic Drug Discovery Investigative Techniques Epidemiologic Methods Health Care Evaluation Mechanisms Quality of Health Care Public Health Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Clinical Trials as Topic Drug Evaluation Medicine Health & Biological Sciences Medical Research |
| Soggetto genere / forma |
Computer network resources.
Electronic books Electronic books. |
| ISBN |
1-280-55482-7
9786610554829 0-470-32599-2 0-470-84626-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910134831103321 |
|
Bohaychuk Wendy
|
||
| Chichester ; ; New York, : John Wiley, c1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]]
| Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]] |
| Autore | Bohaychuk Wendy |
| Pubbl/distr/stampa | Chichester ; ; New York, : John Wiley, c1999 |
| Descrizione fisica | 1 online resource (xiv, 211 p. ) |
| Disciplina | 615/.1901 |
| Altri autori (Persone) | BallGraham |
| Soggetto topico |
Clinical trials - Standards
Drugs - Testing - Standards Onderzoek Geneeskunde Clinical Trials as Topic - standards Drug Evaluation - standards Drug Evaluation, Preclinical Evaluation Studies as Topic Drug Discovery Investigative Techniques Epidemiologic Methods Health Care Evaluation Mechanisms Quality of Health Care Public Health Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Clinical Trials as Topic Drug Evaluation Medicine Health & Biological Sciences Medical Research |
| Soggetto genere / forma |
Computer network resources.
Electronic books. |
| ISBN |
1-280-55482-7
9786610554829 0-470-32599-2 0-470-84626-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910830553503321 |
|
Bohaychuk Wendy
|
||
| Chichester ; ; New York, : John Wiley, c1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]]
| Conducting GCP-compliant clinical research / / Wendy Bohaychuk and Graham Ball [[electronic resource]] |
| Autore | Bohaychuk Wendy |
| Pubbl/distr/stampa | Chichester ; ; New York, : John Wiley, c1999 |
| Descrizione fisica | 1 online resource (xiv, 211 p. ) |
| Disciplina | 615/.1901 |
| Altri autori (Persone) | BallGraham |
| Soggetto topico |
Clinical trials - Standards
Drugs - Testing - Standards Onderzoek Geneeskunde Clinical Trials as Topic - standards Drug Evaluation - standards Drug Evaluation, Preclinical Evaluation Studies as Topic Drug Discovery Investigative Techniques Epidemiologic Methods Health Care Evaluation Mechanisms Quality of Health Care Public Health Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Clinical Trials as Topic Drug Evaluation Medicine Health & Biological Sciences Medical Research |
| Soggetto genere / forma |
Computer network resources.
Electronic books. |
| ISBN |
1-280-55482-7
9786610554829 0-470-32599-2 0-470-84626-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910877497603321 |
|
Bohaychuk Wendy
|
||
| Chichester ; ; New York, : John Wiley, c1999 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
